Global Hospital Cash Benefit Insurance Market Insights, Size and Growth Forecast To 2030

COVID-19
Hospital Cash Benefit Insurance Market- By Term of coverage, By Benefit, By Type, By Service -Regional Outlook, Competitive Strategies and Segment Forecasts to 2030
Request COVID-19
impact analysis

Hospital Cash Benefit Insurance Market- By Term of coverage, By Benefit, By Type, By Service -Regional Outlook, Competitive Strategies and Segment Forecasts to 2030

Published: Aug 2022 Base Year: 2021 Report ID: HLCA2207
Available Format: Historical Data: 2019 - 2020 Number of Pages: 1 - 245
Category : Health Care


According to SPER Market Research, the Hospital Cash Benefit Insurance Market is estimated to reach USD 122.11 billion by 2030 with a CAGR of 14.8%.

The main types of hospital cash benefit insurance are a rider, standalone cover, and part of health insurance. The hospital's cash benefit insurance provides a certain fixed amount to the insured during their hospital stay, which the person is free to use as per his/her need. Hence, an increase in out-of-the-pocket health care expenditure aids in the growth of the hospital's daily cash benefit insurance market. The inability to cover the complete medical treatment expenses is anticipated to hinder the hospital's cash benefit insurance market`s growth. On average, the hospital's daily cash benefit insurance provides the insured with an amount ranging from $100 to $3000 per day which is not sufficient for the complete coverage of the treatment making it a supplement to the health insurance plans. Apollo Munich health insurance is an India-based company formed by the collaboration between Apollo Hospitals and Munich which offers services such as life, health, accident, and travel insurance. 

Impact of COVID-19 on the Hospital Cash Benefit Insurance Market
COVID-19 Impact and Recovery to 2030 provides the strategists, marketers and senior management with the critical information they need to assess the global hospital cash benefit insurance market as it emerges from the COVID-19 shutdown.

Scope of the report:
 Report Metric Details
 Market size available for years 2019-2030
 Base year considered 2021
 Forecast period 2022-2030
 Segments coveredBy Term of coverage, By Benefit, By Type, By Service 
 Geographies coveredNorth America, Europe, Asia Pacific, Latin America, Middle East & Africa
 Companies Covered
Aetna Inc., AIA Insurance Group, Allianz SE, Apollo Munich Health Insurance, Assicurazioni Generali S.p.A., Aviva plc, AXA, Cigna Corporation, Express Scripts Holding Company, ICICI Lombard General Insurance Company, International Medical Group, Religare Health Insurance Company Limited, Star Health Insurance, United Health Group Inc., Zurich Insurance Group Ltd.
Hospital Cash Benefit Insurance Market, By Term of coverage:
Based on the term of coverage, Hospital Cash Benefit Insurance Market is segmented as; Rider, Standalone cover, Part of health insurance.

Hospital Cash Benefit Insurance Market, By Benefit:
Based on the benefit, Hospital Cash Benefit Insurance Market is segmented as; Lifetime coverage, Term Insurance.



Hospital Cash Benefit Insurance Market Global, By Type:
Based on the type, Hospital Cash Benefit Insurance Market is segmented as; Emergency admission, Accident, Medical treatment, Surgery

Hospital Cash Benefit Insurance Market, By Service:
Based on the services, Hospital Cash Benefit Insurance Market is segmented as; Public, Private

Hospital Cash Benefit Insurance Market, By Region:
The regions covered in the hospital cash benefit insurance market report are North America, Europe, Asia Pacific, Latin America, Middle East & Africa.

1. Introduction
1.1. Scope of the report
1.2. Market segment analysis

2. Research Methodology
2.1 Research data source
2.1.1 Secondary data
2.1.2 Primary data
2.1.3 SPER’s internal database
2.1.4 Premium insight from KOL’s
2.2 Market size estimation
2.2.1 Top-down and Bottom-up approach
2.3 Data triangulation

3. Executive Summary

4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges 
4.2. COVID-19 Impacts of the Hospital Cash Benefit Insurance Market 

5. Market variables and outlook
5.1. SWOT analysis 
5.1.1 Strengths 
5.1.2 Weaknesses 
5.1.3 Opportunities
5.1.4 Threats
5.2. PESTEL analysis 
5.2.1 Political landscape
5.2.2 Economic landscape
5.2.3 Social landscape 
5.2.4 Technological landscape 
5.2.5 Environmental landscape 
5.2.6 Legal landscape 
5.3. PORTER’S five forces analysis 
5.3.1 Bargaining power of suppliers 
5.3.2 Bargaining power of Buyers 
5.3.3 Threat of Substitute 
5.3.4 Threat of new entrant 
5.3.5 Competitive rivalry
5.4. Heat map analysis

6. Hospital Cash Benefit Insurance Market, By Term of coverage, 2019-2030 (USD Million)
6.1.  Lifetime coverage
6.2.  Term Insurance

7. Hospital Cash Benefit Insurance Market, By Benefit, 2019-2030 (USD Million)
7.1. Emergency admission
7.2. Accident
7.3. Medical treatment
7.4. Surgery

8. Hospital Cash Benefit Insurance Market, By Type, 2019-2030 (USD Million)
8.1. Rider
8.2. Standalone cover
8.3. Part of health insurance

9. Hospital Cash Benefit Insurance Market, By Service, 2019-2030 (USD Million)
9.1. Public
9.2. Private

10. Hospital Cash Benefit Insurance Market, By Region, 2019-2030 (USD Million)
10.1. North America
10.1.1. United States
10.1.2. Canada
10.1.3. Mexico
10.2. Europe
10.2.1. Germany
10.2.2. United Kingdom
10.2.3. France
10.2.4. Italy
10.2.5. Spain
10.2.6. Rest of Europe
10.3. Asia-Pacific
10.3.1. China
10.3.2. Japan
10.3.3. India
10.3.4. Australia
10.3.5. South Korea
10.3.6. Rest of Asia-Pacific
10.4. South America
10.4.1. Brazil
10.4.2. Argentina
10.4.3. Rest of South America
10.5. Middle East & Africa
10.5.1. Kingdom of Saudi Arabia 
10.5.2. United Arab Emirates
10.5.3. Rest of Middle East & Africa

11. Company Profiles
11.1 Aetna Inc. 
11.1.1 Company details 
11.1.2 Financial outlook
11.1.3 Product summary 
11.1.4 Recent developments
11.2 AIA Insurance Group 
11.2.1 Company details 
11.2.2 Financial outlook
11.2.3 Product summary 
11.2.4 Recent developments
11.3 Allians SE 
11.3.1 Company details 
11.3.2 Financial outlook
11.3.3 Product summary 
11.3.4 Recent developments
11.4 Apollo Munich Health Insurance 
11.4.1 Company details 
11.4.2 Financial outlook
11.4.3 Product summary 
11.4.4 Recent developments
11.5 Assicurazioni Generali SpA 
11.5.1 Company details 
11.5.2 Financial outlook
11.5.3 Product summary 
        11.5.4 Recent developments
11.6 Aviva plc 
11.6.1 Company details 
11.6.2 Financial outlook
11.6.3 Product summary 
11.6.4 Recent developments
11.7 AXA 
11.7.1 Company details 
11.7.2 Financial outlook
11.7.3 Product summary 
11.7.4 Recent developments
11.8 Cigna Corporation
11.8.1 Company details 
11.8.2 Financial outlook
11.8.3 Product summary 
11.8.4 Recent developments
11.9 Express Scripts Holding Company 
11.9.1 Company details
11.9.2 Financial outlook
11.9.3 Product summary
11.9.4 Recent developments
11.10 ICICI Lombard General Insurance Company 
11.10.1 Company details 
11.10.2 Financial outlook
11.10.3 Product summary 
11.10.4 Recent developments
11.11 International Medical Group 
11.11.1 Company details 
11.11.2 Financial outlook
11.11.3 Product summary 
11.11.4  Recent developments
11.12 Religare Health Insurance Company Ltd.
11.12.1 Company details 
11.12.2 Financial outlook
11.12.3  Product summary 
11.12.3  Recent developments
11.13 Star Health Insurance
11.13.1  Company details 
11.13.2  Financial outlook
11.13.3  Product summary 
11.13.3  Recent developments
11.14 United Health Group Inc. 
11.14.1  Company details 
11.14.2  Financial outlook
11.14.3   Product summary 
11.14.3   Recent developments
11.15 Zurich Insurance Group Ltd. 
11.15.1   Company details 
11.15.2    Financial outlook
11.15.3   Product summary 
11.15.4   Recent developments

SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.

The report is based on in-depth qualitative and quantitative analysis of the Global Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings.  The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.

SPER-Methodology-1

SPER-Methodology-2

SPER-Methodology-3

Not able to find what you are looking for? Need customization in the existing report?
Click Here
PLACE AN ORDER
  • 15% off
     
    $ 4250
  • 20% off
             
    $ 5650
  • 25% off
         
    $ 7450
Pre-Purchase Inquiry
SEND AN INQUIRY
NEED CUSTOMIZATION?
Request Customization
100% Secure Payment

SPER American Express
SPER VISA
SPER Master Card
SPER Mestro
SPER Paypal
SPER CCAvenues

Join SPER Panel

Our Global Clients

Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
SPER-Astellas Pharma
SPER-Citi Bank
SPER-Microsoft
SPER-EY
SPER-Sanofi
SPER-p&g
SPER-Johnson & Johnson
SPER-SIEMENS
SPER-LOREAL
SPER-Pfizer
SPER-IPSOS
SPER-Heineken
SPER-IQVIA
SPER-Kankar IMRB
SPER-Astellas Pharma
SPER-Citi Bank
SPER-Microsoft
SPER-EY
SPER-Sanofi
SPER-p&g
SPER-Johnson & Johnson
SPER-SIEMENS
SPER-LOREAL
SPER-Pfizer
SPER-IPSOS
SPER-Heineken
SPER-IQVIA
SPER-Kankar IMRB

SPER

Market Research

We are the leading, full-service global market research and consulting company.

Certificates
iso-1 iso-1
Secure Payments
SPER Payment Options
Connect with us